Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Normal Responders”

60 trials

Showing 20 of 60 results

Testing effectiveness (Phase 2)Looking for participantsNCT04758000
What this trial is testing

Metformin as Maintenance Therapy in Patients With Bone Sarcoma and High Risk of Relapse

Who this might be right for
OsteosarcomaEwing Sarcoma
Istituto Ortopedico Rizzoli 67
Not applicableStudy completedNCT02354963
What this trial is testing

Follicular Activation in Poor Responders

Who this might be right for
Infertility
César Díaz García 34
Early research (Phase 1)Looking for participantsNCT07171983
What this trial is testing

Evaluate the Safety, Tolerability, and Drug Levels of BMS-986454 in Participants With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Bristol-Myers Squibb 46
Testing effectiveness (Phase 2)UnknownNCT04922398
What this trial is testing

Ovarian Injection of PRP (Platelet -Rich Plasma) Vs Normal Saline in Premature Ovarian Insufficiency

Who this might be right for
Premature Ovarian Failure
Ahmed Saad 60
Large-scale testing (Phase 3)Study completedNCT02293902
What this trial is testing

A Study Assessing the Efficacy and Safety of Sarilumab Added to MTX in Japanese Patients With Moderately to Severely Active Rheumatoid Arthritis (SARIL-RA-KAKEHASI)

Who this might be right for
Rheumatoid Arthritis
Sanofi 243
Post-approval studies (Phase 4)Study completedNCT03649061
What this trial is testing

COBRA-Slim With or Without Fast Access to TNF Blockade for Remission Induction in Early RA

Who this might be right for
Arthritis, Rheumatoid
P. Verschueren 276
Not applicableLooking for participantsNCT06572930
What this trial is testing

Serum FSH Monitoring for Identification of an Optimal Range During Ovarian Stimulation

Who this might be right for
Ovarian Stimulation
ART Fertility Clinics LLC 150
Post-approval studies (Phase 4)Study completedNCT02731560
What this trial is testing

Rituximab (RTX) for Disease Modifying Anti Rheumatic Drug (DMARD) Non-responders in Pakistan: The Pakistan Rituximab Study (PARIS)

Who this might be right for
Rheumatoid Arthritis
Prof. Abid Z. Farooqi 74
Large-scale testing (Phase 3)Not Yet RecruitingNCT07346235
What this trial is testing

150 IU vs. 225 IU FSH in Normal Responders: The OPTIMAL-DOSE Trial

Who this might be right for
Infertility, Female
American Hospital 2 Kosovo 440
Large-scale testing (Phase 3)Study completedNCT01768572
What this trial is testing

To Evaluate The Safety of SAR153191 (REGN88) and Tocilizumab Added to Other RA Drugs in Patients With RA Who Are Not Responding to or Intolerant of Anti-TNF Therapy (SARIL-RA-ASCERTAIN)

Who this might be right for
Rheumatoid Arthritis
Sanofi 202
Large-scale testing (Phase 3)Study completedNCT01412944
What this trial is testing

Efficacy and Safety of Intravenous and Subcutaneous Secukinumab in Moderate to Severe Chronic Plaque-type Psoriasis

Who this might be right for
Plaque-type Psoriasis
Novartis Pharmaceuticals 43
Post-approval studies (Phase 4)Study completedNCT05108558
What this trial is testing

Efficacy of a Novel CCH Protocol for PD Among Prior Non-responders

Who this might be right for
Peyronie's Disease
Charitable Union for the Research and Education of Peyronie's Disease 40
Not applicableEnded earlyNCT01367691
What this trial is testing

Cardiac MR (CMR) in Cardiac Resynchronization Therapy Non-responders

Who this might be right for
Heart Failure
University Hospital, Bonn 1
Post-approval studies (Phase 4)Study completedNCT01147341
What this trial is testing

Can TNF-Alpha Incomplete Secondary Responders Attain a Safe and Efficacious Response Switching to Cimzia

Who this might be right for
Rheumatoid Arthritis
Michael Schiff, MD 37
Large-scale testing (Phase 3)Study completedNCT01709578
What this trial is testing

To Evaluate The Effect Of SAR153191 (REGN88) Added To Other RA Drugs In Patients With RA Who Are Not Responding To Or Intolerant Of Anti-TNF Therapy (SARIL-RA-TARGET)

Who this might be right for
Rheumatoid Arthritis
Sanofi 546
Testing effectiveness (Phase 2)Ended earlyNCT01636843
What this trial is testing

A Trial of NNC0109-0012, an Anti-IL-20 Biologic, in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to Methotrexate

Who this might be right for
InflammationRheumatoid Arthritis
Novo Nordisk A/S 298
Testing effectiveness (Phase 2)Study completedNCT00134394
What this trial is testing

Etanercept With Tacrolimus for Psoriasis

Who this might be right for
Psoriasis
University of Medicine and Dentistry of New Jersey 20
Post-approval studies (Phase 4)UnknownNCT03227419
What this trial is testing

Abatacept vs Tocilizumab for the Treatment of RA in TNF Alpha Inhibitor Inadequate Responders

Who this might be right for
Arthritis, Rheumatoid
Lille Catholic University 224
Not applicableStudy completedNCT05394792
What this trial is testing

An Observational Study of Upadacitinib to Assess Change in Disease Activity in Canadian Adult Participants With Moderate-to-Severe Atopic Dermatitis Who Are Inadequate Responders To or Discontinuing Dupilumab

Who this might be right for
Atopic Dermatitis
AbbVie 111
Large-scale testing (Phase 3)Looking for participantsNCT06873945
What this trial is testing

2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata

Who this might be right for
Alopecia Areata
Pfizer 674
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation